Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Ken Fisher Loses More Than $80 Million After $ORCL Drops More Than 13%

Oracle Corp (ORCL) slumps after the company reported its results for the second quarter. According to Market Watch, Oracle would have earned $2.8 billion, or 54 cents a share, which fell short of a FactSet Research analyst forecast for 57 cents a share, on revenue of $9.23 billion. The company’s net income rose 17.2% and revenue rose 2% from the same quarter a year earlier. ORCL is trading at $25.25 at 12:04PM EST on Wednesday, down 13.46% from Tuesday’s close price.

FISHER ASSET MANAGEMENT

Here is a list of hedge funds that may reveal large losses due to ORCL’s drop:

1. Fisher Asset Management – Ken Fisher: Loses $80.24 million

2. Cantillon Capital Management – William von Mueffling: Loses $29.78 million

3. Columbus Circle Investors – Donald Chiboucis: Loses $24.55 million

4. Maverick Capital – Lee Ainslie: Loses $24.42 million

5. Adage Capital Management – Phill Gross and Robert Atchinson: Loses $21.32 million

6. Steadfast Capital Management – Robert Pitts: Loses $19.79 million

7. Farallon Capital – Thomas Steyer: Loses $17.60 million

8. Eminence Capital – Ricky Sandler: Loses $14.71 million

9. Citadel Investment Group – Ken Griffin: Loses $10.86 million

10. Childrens Investment Fund – Chris Hohn: Loses $10.63 million

DISCLAIMER: These calculations assume that these hedge funds did not increase or reduce their stock positions in ORCL since the end of September. We did not take into account their option positions.

Biotech Insider Alert - $5 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!